T. Tominaga et al., EFFECTS OF TYB-2285 ON THE ACCUMULATION OF EOSINOPHILS IN THE AIRWAY INDUCED BY ANTIGEN EXPOSURE IN ACTIVELY SENSITIZED BROWN-NORWAY RATS, General pharmacology, 28(2), 1997, pp. 301-303
I, The effect of TYB-2285 on the antigen induced accumulation of eosin
ophils into the airway was investigated in two models (inhalant sensit
ization and noninhalant sensitization) using Brown Norway (BN) rats. 2
. In the method of inhalant sensitization, BN rats were sensitized by
weekly exposure to ovalbumin (OA). The accumulation of eosinophils was
inhibited by the oral administration of TYB-2285 for the first 2 days
of each sensitization in a dose dependent manner. 3. With noninhalant
sensitization, BN rats were sensitized by TM injection of OA and TP i
njection of killed Bordetella pertussis. The accumulation of eosinophi
ls was inhibited by TYB-2285 in a dose-dependent manner, when TYB-2285
is given PO 5 mm before and 5 hr after the antigen exposure. Moreover
, this accumulation of eosinophils was inhibited by a single administr
ation of TYB-2285 5 hr after the antigen exposure, presumably when the
mast cell degranulation was already finished. 4. In the method with n
oninhalant sensitization, the accumulation of eosinophils was not inhi
bited by mast cell stabilizers such as ketotifen, tranilast, or DSCG.
5. The present study demonstrates that TYB-2285, unlike other mast cel
l stabilizers, inhibits the antigen-induced accumulation of eosinophil
s into the airway. It also suggests that this drug might be effective
in asthmatic patients. Copyright (C) 1997 Elsevier Science Inc.